The Gastrointestinal Agents Market is experiencing robust growth driven by rising prevalence of gastrointestinal (GI) disorders such as inflammatory bowel disease, gastroesophageal reflux disease, and peptic ulcer disease. This growth is further supported by an expanding adult population more susceptible to chronic GI conditions, creating a larger patient base and higher demand for specialized...